We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

169 hedge funds and large institutions have $1.01B invested in DermTech, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

646% more first-time investments, than exits

New positions opened: 97 | Existing positions closed: 13

167% more capital invested

Capital invested by funds: $380M → $1.01B (+$634M)

115% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 20

99% more funds holding

Funds holding: 85169 (+84)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

24% more call options, than puts

Call options by funds: $35M | Put options by funds: $28.2M

Holders
169
Holders Change
+84
Holders Change %
+98.82%
% of All Funds
2.97%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
97
Increased
43
Reduced
20
Closed
13
Calls
$35M
Puts
$28.2M
Net Calls
+$6.8M
Net Calls Change
+$7.04M
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$6.91M +$6.31M +120,666 +785%
IM
27
Islet Management
New York
$6.35M +$6.54M +125,000 New
BM
28
Bridger Management
New York
$6.24M -$3M -57,427 -32%
Deutsche Bank
29
Deutsche Bank
Germany
$6.11M +$5.97M +114,085 +1,843%
LCG
30
Lisanti Capital Growth
New York
$5.84M +$6.01M +114,945 New
Jane Street
31
Jane Street
New York
$5.34M +$4.4M +84,219 +403%
TCM
32
Tygh Capital Management
Oregon
$5.08M +$4.18M +79,947 +400%
CS
33
Credit Suisse
Switzerland
$4.72M +$59.6K +1,140 +1%
TA
34
Tamarack Advisers
California
$4.27M +$3.09M +59,000 +236%
GIA
35
Gladstone Institutional Advisory
Florida
$4.15M +$4.28M +81,745 New
Citadel Advisors
36
Citadel Advisors
Florida
$4.05M +$3.63M +69,312 +658%
Citigroup
37
Citigroup
New York
$3.97M +$4.01M +76,655 +4,914%
FA
38
Friess Associates
Delaware
$3.58M +$3.68M +70,433 New
Fuller & Thaler Asset Management
39
Fuller & Thaler Asset Management
California
$3.45M -$327K -6,260 -8%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$3.16M +$3.25M +62,228 New
EMFAT
41
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.05M +$3.14M +60,000 New
BAM
42
Belpointe Asset Management
Nevada
$2.92M +$157K +3,000 +6%
GGHC
43
Gilder Gagnon Howe & Co
New York
$2.84M +$2.92M +55,863 New
ETCM
44
Evolutionary Tree Capital Management
Virginia
$2.72M +$2.8M +53,601 New
WMC
45
Westwood Management Corporation
Illinois
$2.59M +$2.67M +51,000 New
Bank of New York Mellon
46
Bank of New York Mellon
New York
$2.56M +$1.01M +19,398 +63%
N
47
Nuveen
North Carolina
$2.45M +$728K +13,921 +41%
LSA
48
L & S Advisors
California
$2.32M +$2.39M +45,615 New
BPIM
49
Brant Point Investment Management
New York
$2.29M -$523K -10,000 -18%
GAMA
50
Graticule Asia Macro Advisors
New York
$2.29M +$2.35M +44,987 New

DMTK Hedge Fund Activity: Q1 2021 in Review

169 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2021, worth a combined $1.01B — up 167% from $380M a quarter earlier.

Buyers outnumbered sellers: 97 funds opened new DMTK positions and 13 closed out — a net gain of 84 holders — while 43 added to existing stakes and 20 trimmed.

The largest buyer was ISZO Capital Management, adding an estimated $70.5M. The largest seller was Farallon Capital Management, cutting an estimated $34.6M.

  • 169 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2021, up from 85 in Q4 2020.
  • Funds reported $1.01B of DermTech, Inc. Common Stock stock for Q1 2021, up 167% quarter-over-quarter.
  • 97 funds opened new DermTech, Inc. Common Stock positions in Q1 2021 and 13 closed out, a net change of +84 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q1 2021 was ISZO Capital Management, an estimated $70.5M added.
  • The largest DermTech, Inc. Common Stock seller in Q1 2021 was Farallon Capital Management, an estimated $34.6M sold.

Based on aggregated 13F filings for Q1 2021.